Yuko Muto Selected Research

Yuko Muto Research Topics

2	Infections 06/2022 - 03/2008
1	Anemia 06/2022
1	Hemolytic Anemia 06/2022
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 06/2022
1	COVID-19 06/2022
1	Cough 06/2022
1	Dyspnea (Shortness of Breath) 06/2022
1	Monoclonal Gammopathy of Undetermined Significance 06/2022
1	Endotoxemia 05/2009
1	Sepsis (Septicemia) 05/2009
1	Pancreatitis 03/2008
1	Atherosclerosis 03/2007
1	Glomerulonephritis 01/2007
1	Edema (Dropsy) 01/2007
1	Thrombosis (Thrombus) 05/2004

3	7- amino- 2- (((2- methyl- 1- (3- phenylpropanoylamino)propyl)hydroxyphosphinoyl)methyl)heptanoic acidIBA 05/2009 - 05/2004
2	Anti-Bacterial Agents (Antibiotics)IBA 05/2009 - 03/2008
1	Hemoglobins (Hemoglobin)IBA 06/2022
1	Immunoglobulin M (IgM)IBA 06/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2022
1	AgglutininsIBA 06/2022
1	LipopolysaccharidesIBA 05/2009
1	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 05/2009
1	Ceftazidime (Fortum)FDA LinkGeneric 05/2009
1	FibrinIBA 05/2009
1	Fibrinogen (Factor I)FDA Link 05/2009
1	biapenem (L 627)IBA 03/2008
1	Taurocholic Acid (Sodium Taurocholate)IBA 03/2008
1	Imipenem FDA Link 03/2008
1	Carbapenems (Carbapenem Antibiotics)IBA 03/2008
1	PolyphenolsIBA 03/2007
1	Proanthocyanidins (Procyanidins)IBA 03/2007
1	oxidized low density lipoproteinIBA 03/2007
1	Urea (Carbamide)FDA LinkGeneric 01/2007
1	NitrogenIBA 01/2007
1	Carboxypeptidase BIBA 01/2007
1	AcidsIBA 05/2004
1	Phosphinic Acids (Phosphinic Acid)IBA 05/2004

1	Therapeutics 06/2022
1	Intravenous Injections 05/2009